Key result
Percutaneous LAAO carries a ~2% pooled incidence of device-related thrombus across 12 studies.
Why the study?
Device-related thrombus is a clinically important complication associated with increased thromboembolic risk after left atrial appendage occlusion, but its reported incidence varies substantially across studies.
What is the pooled incidence and between-study variability of device-related thrombus in adults with atrial fibrillation undergoing percutaneous left atrial appendage occlusion?
Meta-Analysis (n=7,328)
Yes
What is the pooled incidence and between-study variability of device-related thrombus in adults with atrial fibrillation undergoing percutaneous left atrial appendage occlusion?
Device-related thrombus occurs in approximately 1 in 43 patients after percutaneous LAAO with substantial device- and study-level variability, underscoring the need for standardized post-procedural imaging surveillance.
Answers are grounded in this paper and cite their sources.
Warrants standardized post-LAAO imaging surveillance; extends incidence data but leaves optimal protocols open amid high heterogeneity.
Background: Device-related thrombus (DRT) remains a clinically important complication following left atrial appendage occlusion (LAAO), as it is associated with increased thromboembolic risk. Reported DRT incidence varies substantially across studies. We performed a systematic review and meta-analysis to estimate DRT incidence after LAAO and evaluate between-study heterogeneity. Methods: PubMed and Google Scholar were systematically searched for studies evaluating DRT after percutaneous LAAO in adults with atrial fibrillation. Studies were required to include systematic post-procedural imaging surveillance for DRT. Studies exclusively enrolling patients with established DRT were excluded. Random-effects meta-analysis with logit transformation was used to pool incidence estimates. Heterogeneity was assessed using I 2 and τ 2 statistics. Prediction intervals, leave-one-out sensitivity analyses, and Egger's regression test were performed. Results: Twelve studies comprising 7,328 patients and 154 DRT events were included. The pooled incidence of DRT was 2.32% (95% CI, 1.47%-3.64%). Substantial heterogeneity was observed (I 2 =78.2%, τ 2 =0.39). The 95% prediction interval ranged from approximately 1% to 9%, indicating considerable variation in DRT incidence across clinical settings. Heterogeneity remained high among randomized trials alone (I 2 =83.4%). Sensitivity analyses identified the Amulet IDE trial (n=1,833; DRT incidence 0.49%) as a major contributor to heterogeneity; exclusion of this study reduced heterogeneity among randomized trials to I 2 =24.6% (p=0.26). Leave-one-out analyses demonstrated stable pooled estimates ranging from 2% to 3%. Egger's test showed no evidence of publication bias (p=0.71). Conclusions: DRT occurs in approximately 1 in 43 patients undergoing LAAO, with substantial variability across studies and clinical settings. Device-specific differences may contribute significantly to this heterogeneity. These findings support the need for standardized surveillance strategies and further investigation into device-specific approaches to DRT prevention and management.
No takes yet. Share an insight, caveat, or question.
Garikipati et al. (2026) conducted a meta-analysis in Atrial fibrillation undergoing percutaneous left atrial appendage occlusion (n=7,328). Percutaneous left atrial appendage occlusion (LAAO) was evaluated on Pooled incidence of device-related thrombus (DRT) (Pooled incidence 2.32%, 95% CI 1.47-3.64). Percutaneous left atrial appendage occlusion was associated with a pooled device-related thrombus incidence of 2.32% across 12 studies.
Synapse has enriched 10 related papers. Consider them for comparative context: